560 related articles for article (PubMed ID: 19663124)
21. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients.
Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Lai CK; Hui DS
Clin Exp Allergy; 2006 Jan; 36(1):44-51. PubMed ID: 16393265
[TBL] [Abstract][Full Text] [Related]
22. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control.
Melosini L; Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Paggiaro P
J Asthma; 2012 Apr; 49(3):317-23. PubMed ID: 22401649
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.
Robroeks CM; van de Kant KD; van Vliet D; Kester AD; Hendriks HJ; Damoiseaux JG; Wodzig WK; Rijkers GT; Dompeling E; Jöbsis Q
Ann Allergy Asthma Immunol; 2008 Jun; 100(6):601-7. PubMed ID: 18592826
[TBL] [Abstract][Full Text] [Related]
24. Modifications in forced vital capacity during adenosine monophosphate-induced bronchoconstriction in asthma: relationship with the response to methacholine and the effect of inhaled corticosteroids.
Prieto L; López V; Catalan P; Barato D; Marín J
Ann Allergy Asthma Immunol; 2009 May; 102(5):393-9. PubMed ID: 19492660
[TBL] [Abstract][Full Text] [Related]
25. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
Harnest U; Price D; Howes T; Sussman G
J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
[TBL] [Abstract][Full Text] [Related]
26. Maximal response plateau to adenosine 5'-monophosphate in asthma. Relationship with the response to methacholine, exhaled nitric oxide, and exhaled breath condensate pH.
Prieto L; Esnal S; Lopez V; Barato D; Rojas R; Marín J
Chest; 2009 Jun; 135(6):1521-1526. PubMed ID: 19225062
[TBL] [Abstract][Full Text] [Related]
27. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
Magnussen H; Willenbrock U; Jörres R
Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
[TBL] [Abstract][Full Text] [Related]
28. Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children.
Carrà S; Gagliardi L; Zanconato S; Scollo M; Azzolin N; Zacchello F; Baraldi E
Respir Med; 2001 Sep; 95(9):734-9. PubMed ID: 11575894
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory markers in exhaled breath condensate from patients with asthma.
Ueno T; Kataoka M; Hirano A; Iio K; Tanimoto Y; Kanehiro A; Okada C; Soda R; Takahashi K; Tanimoto M
Respirology; 2008 Sep; 13(5):654-63. PubMed ID: 18513240
[TBL] [Abstract][Full Text] [Related]
30. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients.
Zietkowski Z; Bodzenta-Lukaszyk A; Tomasiak MM; Skiepko R; Szmitkowski M
J Investig Allergol Clin Immunol; 2006; 16(4):239-46. PubMed ID: 16889281
[TBL] [Abstract][Full Text] [Related]
31. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
32. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.
Horváth I; Donnelly LE; Kiss A; Kharitonov SA; Lim S; Chung KF; Barnes PJ
Am J Respir Crit Care Med; 1998 Oct; 158(4):1042-6. PubMed ID: 9769258
[TBL] [Abstract][Full Text] [Related]
33. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height.
Visser MJ; Postma DS; Arends LR; de Vries TW; Duiverman EJ; Brand PL
Am J Respir Crit Care Med; 2001 Dec; 164(11):2073-7. PubMed ID: 11739137
[TBL] [Abstract][Full Text] [Related]
34. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.
Ojoo JC; Mulrennan SA; Kastelik JA; Morice AH; Redington AE
Thorax; 2005 Jan; 60(1):22-6. PubMed ID: 15618578
[TBL] [Abstract][Full Text] [Related]
35. Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis.
Leung TF; Wong GW; Ko FW; Lam CW; Fok TF
Thorax; 2005 Oct; 60(10):822-6. PubMed ID: 16055623
[TBL] [Abstract][Full Text] [Related]
36. Effects of inhaled versus systemic corticosteroids on exhaled nitric oxide in severe acute asthma.
Khoo SM; Lim TK
Respir Med; 2009 Apr; 103(4):614-20. PubMed ID: 19022641
[TBL] [Abstract][Full Text] [Related]
37. Effects of low-dose fluticasone propionate/salmeterol combination therapy on exhaled nitric oxide and nitrite/nitrate in breath condensates from patients with mild persistent asthma.
Pasha MA; Smith TC; Feustel PJ; Jourd'heuil D
J Asthma; 2013 Feb; 50(1):64-70. PubMed ID: 23098359
[TBL] [Abstract][Full Text] [Related]
38. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
39. Comparison of eNO and histamine hyperresponsiveness in diagnosing asthma in new referrals.
Munnik P; van der Lee I; Fijn J; van Eijsden LJ; Lammers JW; Zanen P
Respir Med; 2010 Jun; 104(6):801-7. PubMed ID: 20036525
[TBL] [Abstract][Full Text] [Related]
40. Airway hyperresponsiveness, peak flow variability and inflammatory markers in non-asthmatic subjects with respiratory infections.
Björnsson E; Lúdvíksdóttir D; Hedenström H; Eriksson BM; Högman M; Venge P; Janson C
Clin Respir J; 2007 Jul; 1(1):42-50. PubMed ID: 20298277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
